保険解約損、研究開発費
- 【期間】
年度 | 保険解約損 | 研究開発費 |
---|
2010/03 | - | | 45.4億 | |
2010/06 | - | | 10.5億 | -77% |
2010/09 | - | | 22.1億 | +111.7% |
2010/12 | - | | 34億 | +53.6% |
2011/03 | - | | 44.2億 | +29.9% |
2011/06 | - | | 11.9億 | -73.1% |
2011/09 | - | | 21.5億 | +81.6% |
2011/12 | - | | 32.6億 | +51.1% |
2012/03 | - | | 43.8億 | +34.7% |
2012/06 | - | | 11.2億 | -74.5% |
2012/09 | - | | 22.1億 | +97.8% |
2012/12 | - | | 33.7億 | +52.4% |
2013/03 | - | | 42.9億 | +27.2% |
2013/06 | - | | 12.9億 | -70% |
2013/09 | - | | 22.4億 | +74.4% |
2013/12 | - | | 33.6億 | +49.9% |
2014/03 | - | | 45.1億 | +34.2% |
2014/06 | - | | 15.2億 | -66.3% |
2014/09 | - | | 29.2億 | +91.8% |
2014/12 | - | | 41.9億 | +43.6% |
2015/03 | - | | 55.2億 | +31.7% |
2015/06 | - | | 13億 | -76.5% |
2015/09 | - | | 30.6億 | +136.6% |
2015/12 | - | | 48.1億 | +57.1% |
2016/03 | - | | 64.8億 | +34.6% |
2016/06 | - | | 18.7億 | -71.1% |
2016/09 | - | | 36.4億 | +94% |
2016/12 | - | | 50.3億 | +38.5% |
2017/03 | - | | 61.3億 | +21.8% |
2017/06 | - | | 13.5億 | -78% |
2017/09 | - | | 26.9億 | +99% |
2017/12 | - | | 40.9億 | +52.1% |
2018/03 | - | | 60.4億 | +47.7% |
2018/06 | - | | 16.9億 | -72% |
2018/09 | - | | 34億 | +100.9% |
2018/12 | - | | 51.9億 | +52.6% |
2019/03 | - | | 71.8億 | +38.5% |
2019/06 | - | | 18.6億 | -74.2% |
2019/09 | - | | 37.1億 | +99.9% |
2019/12 | - | | 56億 | +50.8% |
2020/03 | - | | 77.6億 | +38.6% |
2020/06 | - | | 20.9億 | -73.1% |
2020/09 | - | | 39.3億 | +88.3% |
2020/12 | - | | 57.8億 | +47.1% |
2021/03 | - | | 80.6億 | +39.5% |
2021/06 | - | | 20.5億 | -74.6% |
2021/09 | - | | 41.3億 | +101.6% |
2021/12 | - | | 61.9億 | +50.1% |
2022/03 | - | | 85.2億 | +37.5% |
2022/06 | - | | 22.7億 | -73.4% |
2022/09 | - | | 45.1億 | +98.8% |
2022/12 | - | | 68.1億 | +50.9% |
2023/03 | 9百万 | | 104億 | +52.7% |
2023/06 | 39百万 | +333.3% | 27.2億 | -73.8% |
2023/09 | 41百万 | +5.1% | 52.6億 | +93.5% |
2023/12 | 41百万 | ±0% | 76.7億 | +45.9% |
2024/03 | 41百万 | ±0% | 103億 | +33.8% |
2024/06 | 24百万 | -41.5% | 35.9億 | -65.1% |